A chronic inflammatory response dominates the skeletal muscle molecular signature in dystrophin-deficient mdx mice - PubMed (original) (raw)
. 2002 Feb 1;11(3):263-72.
doi: 10.1093/hmg/11.3.263.
Affiliations
- PMID: 11823445
- DOI: 10.1093/hmg/11.3.263
A chronic inflammatory response dominates the skeletal muscle molecular signature in dystrophin-deficient mdx mice
John D Porter et al. Hum Mol Genet. 2002.
Abstract
Mutations in dystrophin cause Duchenne muscular dystrophy (DMD), but absent dystrophin does not invariably cause necrosis in all muscles, life stages and species. Using DNA microarray, we established a molecular signature of dystrophinopathy in the mdx mouse, with evidence that secondary mechanisms are key contributors to pathogenesis. We used variability controls, adequate replicates and stringent analytic tools, including significance analysis of microarrays to estimate and manage false positive rates. In leg muscle, we identified 242 differentially expressed genes, >75% of which have not been previously reported as altered in human or animal dystrophies. Data provide evidence for coordinated activity of numerous components of a chronic inflammatory response, including cytokine and chemokine signaling, leukocyte adhesion and diapedesis, invasive cell type-specific markers, and complement system activation. Selective chemokine upregulation was confirmed by RT-PCR and immunoblot, and may be a key determinant of the nature of the inflammatory response in dystrophic muscle. Up-regulation of secreted phosphoprotein 1 (minopontin, osteopontin) mRNA and protein in dystrophic muscle identified a novel linkage between inflammatory cells and repair processes. Extracellular matrix genes were up-regulated in mdx to levels similar to those in DMD. Since, unlike DMD, mdx exhibits little fibrosis, data suggest that collagen regulation at post-transcriptional stages mediates extensive fibrosis in DMD. Taken together, these data identify a relatively neglected aspect of DMD, suggest new treatment avenues, and highlight the value of genome-wide profiling in study of complex disease processes.
Similar articles
- Dissection of temporal gene expression signatures of affected and spared muscle groups in dystrophin-deficient (mdx) mice.
Porter JD, Merriam AP, Leahy P, Gong B, Khanna S. Porter JD, et al. Hum Mol Genet. 2003 Aug 1;12(15):1813-21. doi: 10.1093/hmg/ddg197. Hum Mol Genet. 2003. PMID: 12874102 - Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
Church JE, Trieu J, Chee A, Naim T, Gehrig SM, Lamon S, Angelini C, Russell AP, Lynch GS. Church JE, et al. Exp Physiol. 2014 Apr;99(4):675-87. doi: 10.1113/expphysiol.2013.077255. Epub 2014 Jan 17. Exp Physiol. 2014. PMID: 24443351 - Cloning of cDNA encoding a regeneration-associated muscle protease whose expression is attenuated in cell lines derived from Duchenne muscular dystrophy patients.
Nakayama Y, Nara N, Kawakita Y, Takeshima Y, Arakawa M, Katoh M, Morita S, Iwatsuki K, Tanaka K, Okamoto S, Kitamura T, Seki N, Matsuda R, Matsuo M, Saito K, Hara T. Nakayama Y, et al. Am J Pathol. 2004 May;164(5):1773-82. doi: 10.1016/S0002-9440(10)63735-2. Am J Pathol. 2004. PMID: 15111323 Free PMC article. - The value of mammalian models for duchenne muscular dystrophy in developing therapeutic strategies.
Banks GB, Chamberlain JS. Banks GB, et al. Curr Top Dev Biol. 2008;84:431-53. doi: 10.1016/S0070-2153(08)00609-1. Curr Top Dev Biol. 2008. PMID: 19186250 Review. - The Role of P2X7 Purinoceptors in the Pathogenesis and Treatment of Muscular Dystrophies.
Zabłocki K, Górecki DC. Zabłocki K, et al. Int J Mol Sci. 2023 May 29;24(11):9434. doi: 10.3390/ijms24119434. Int J Mol Sci. 2023. PMID: 37298386 Free PMC article. Review.
Cited by
- Protective action of ultrasound-guided electrolysis technique on the muscle damage induced by notexin in rats.
Jorda A, Campos-Campos J, Aldasoro C, Colmena C, Aldasoro M, Alvarez K, Valles SL. Jorda A, et al. PLoS One. 2022 Nov 28;17(11):e0276634. doi: 10.1371/journal.pone.0276634. eCollection 2022. PLoS One. 2022. PMID: 36441673 Free PMC article. - Genetic Modifiers of Duchenne Muscular Dystrophy in Chinese Patients.
Chen M, Wang L, Li Y, Chen Y, Zhang H, Zhu Y, He R, Li H, Lin J, Zhang Y, Zhang C. Chen M, et al. Front Neurol. 2020 Jul 29;11:721. doi: 10.3389/fneur.2020.00721. eCollection 2020. Front Neurol. 2020. PMID: 32849198 Free PMC article. - Modifying muscular dystrophy through transforming growth factor-β.
Ceco E, McNally EM. Ceco E, et al. FEBS J. 2013 Sep;280(17):4198-209. doi: 10.1111/febs.12266. Epub 2013 Apr 24. FEBS J. 2013. PMID: 23551962 Free PMC article. Review. - Genomic profiling reveals Pitx2 controls expression of mature extraocular muscle contraction-related genes.
Zhou Y, Gong B, Kaminski HJ. Zhou Y, et al. Invest Ophthalmol Vis Sci. 2012 Apr 18;53(4):1821-9. doi: 10.1167/iovs.12-9481. Invest Ophthalmol Vis Sci. 2012. PMID: 22408009 Free PMC article. - Engineering skeletal muscle repair.
Juhas M, Bursac N. Juhas M, et al. Curr Opin Biotechnol. 2013 Oct;24(5):880-6. doi: 10.1016/j.copbio.2013.04.013. Epub 2013 May 24. Curr Opin Biotechnol. 2013. PMID: 23711735 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
- EY09834/EY/NEI NIH HHS/United States
- EY11998/EY/NEI NIH HHS/United States
- EY12779/EY/NEI NIH HHS/United States
- EY12998/EY/NEI NIH HHS/United States
- P30 EY11373/EY/NEI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials